{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:32:45Z","timestamp":1794004365938,"version":"4.8.0"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T00:00:00Z","timestamp":1621814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Development and progression of immune-mediated inflammatory diseases (IMIDs) involve intricate dysregulation of the disease-associated genes (DAGs) and their expressing immune cells. Identifying the crucial disease-associated cells (DACs) in IMIDs has been challenging due to the underlying complex molecular mechanism.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Using transcriptome profiles of 40 different immune cells, unsupervised machine learning, and disease-gene networks, we constructed the Disease-gene IMmune cell Expression (DIME) network and identified top DACs and DAGs of 12 phenotypically different IMIDs. We compared the DIME networks of IMIDs to identify common pathways between them. We used the common pathways and publicly available drug-gene network to identify promising drug repurposing targets.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We found CD4<jats:sup>+<\/jats:sup>Treg, CD4<jats:sup>+<\/jats:sup>Th1, and NK cells as top DACs in inflammatory arthritis such as ankylosing spondylitis (AS), psoriatic arthritis, and rheumatoid arthritis (RA); neutrophils, granulocytes, and BDCA1<jats:sup>+<\/jats:sup>CD14<jats:sup>+<\/jats:sup> cells in systemic lupus erythematosus and systemic scleroderma; ILC2, CD4<jats:sup>+<\/jats:sup>Th1, CD4<jats:sup>+<\/jats:sup>Treg, and NK cells in the inflammatory bowel diseases (IBDs). We identified lymphoid cells (CD4<jats:sup>+<\/jats:sup>Th1, CD4<jats:sup>+<\/jats:sup>Treg, and NK) and their associated pathways to be important in HLA-B27 type diseases (psoriasis, AS, and IBDs) and in primary-joint-inflammation-based inflammatory arthritis (AS and RA). Based on the common cellular mechanisms, we identified lifitegrast as a potential drug repurposing candidate for Crohn\u2019s disease and other IMIDs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Existing methods are inadequate in capturing the intricate involvement of the crucial genes and cell types essential to IMIDs. Our approach identified the key DACs, DAGs, common mechanisms between IMIDs, and proposed potential drug repurposing targets using the DIME network. To extend our method to other diseases, we built the DIME tool (<jats:uri>https:\/\/bitbucket.org\/systemsimmunology\/dime\/<\/jats:uri>) to help scientists uncover the etiology of complex and rare diseases to further drug development by better-determining drug targets, thereby mitigating the risk of failure in late clinical development.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2021.669400","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T06:23:12Z","timestamp":1621837392000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Integration of Immunome With Disease-Gene Network Reveals Common Cellular Mechanisms Between IMIDs and Drug Repurposing Strategies"],"prefix":"10.3389","volume":"12","author":[{"given":"Abhinandan","family":"Devaprasad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R. D. J.","family":"Radstake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aridaman","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/bs.adgen.2015.11.004","article-title":"Integrative Analysis of Multi-omics Data for Discovery and Functional Studies of Complex Human Diseases","volume":"93","author":"Sun","year":"2016","journal-title":"Adv Genet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004346","article-title":"A Pathway-Based View of Human Diseases and Disease Relationships","volume":"4","author":"Li","year":"2009","journal-title":"PloS One"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1126\/science.aax6648","article-title":"Mapping Human Cell Phenotypes to Genotypes With Single-Cell Genomics","volume":"365","author":"Camp","year":"2019","journal-title":"Sci (80- )"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/550451a","article-title":"The Human Cell Atlas: From Vision to Reality","volume":"550","author":"Rozenblatt-Rosen","year":"2017","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2653","article-title":"The Genotype-Tissue Expression (Gtex) Project","volume":"45","author":"Lonsdale","year":"2013","journal-title":"Nat Genet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1126\/science.1262110","article-title":"The Genotype-Tissue Expression (Gtex) Pilot Analysis: Multitissue Gene Regulation in Humans","volume":"348","author":"Ardlie","year":"2015","journal-title":"Sci (80- )"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nature24277","article-title":"Genetic Effects on Gene Expression Across Human Tissues","volume":"550","year":"2017","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-cancerbio-030518-055609","article-title":"Deciphering Human Tumor Biology by Single-Cell Expression Profiling","volume":"3","author":"Tirosh","year":"2019","journal-title":"Annu Rev Cancer Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A Unique Microglia Type Associated With Restricting Development of Alzheimer\u2019s Disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau8587","article-title":"HBEGF+ Macrophages in Rheumatoid Arthritis Induce Fibroblast Invasiveness","volume":"11","author":"Kuo","year":"2019","journal-title":"Sci Transl Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.tig.2012.10.006","article-title":"Genomic Modulators of the Immune Response","volume":"29","author":"Knight","year":"2013","journal-title":"Trends Genet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1126\/science.1249547","article-title":"Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes","volume":"344","author":"Raj","year":"2014","journal-title":"Sci (80- )"},{"key":"B13","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.cell.2016.09.024","article-title":"Genetic Adaptation and Neandertal Admixture Shaped the Immune System of Human Populations","volume":"167","author":"Quach","year":"2016","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1246980","DOI":"10.1126\/science.1246980","article-title":"Common Genetic Variants Modulate Pathogen-Sensing Responses in Human Dendritic Cells","volume":"343","author":"Lee","year":"2014","journal-title":"Sci (80- )"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1246949","DOI":"10.1126\/science.1246949","article-title":"Innate Immune Activity Conditions the Effect of Regulatory Variants Upon Monocyte Gene Expression","volume":"343","author":"Fairfax","year":"2014","journal-title":"Sci (80- )"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.cell.2016.10.026","article-title":"Genetic Drivers of Epigenetic and Transcriptional Variation in Human Immune Cells","volume":"167","author":"Chen","year":"2016","journal-title":"Cell"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/J.CELL.2018.10.022","article-title":"Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression","volume":"175","author":"Schmiedel","year":"2018","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/cells7100161","article-title":"Pathogenic Role of Immune Cells in Rheumatoid Arthritis: Implications in Clinical Treatment and Biomarker Development","volume":"7","author":"Yap","year":"2018","journal-title":"Cells"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-39132-2","article-title":"Genetic Variants Differentially Associated With Rheumatoid Arthritis and Systemic Lupus Erythematosus Reveal the Disease-Specific Biology","volume":"9","author":"Lim","year":"2019","journal-title":"Sci Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1001","article-title":"Genome-Wide Association Studies in Crohn\u2019s Disease: Past, Present and Future: Past","volume":"7","author":"Verstockt","year":"2018","journal-title":"Clin Transl Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3434","article-title":"Genetic Association Analyses Implicate Aberrant Regulation of Innate and Adaptive Immunity Genes in the Pathogenesis of Systemic Lupus Erythematosus","volume":"47","author":"Bentham","year":"2015","journal-title":"Nat Genet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nature12873","article-title":"Genetics of Rheumatoid Arthritis Contributes to Biology and Drug Discovery","volume":"506","author":"Okada","year":"2014","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw943","article-title":"DisGeNET: A Comprehensive Platform Integrating Information on Human Disease-Associated Genes and Variants","volume":"45","author":"Pi\u00f1ero","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: Ultrafast Universal RNA-seq Aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map Format and Samtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu638","article-title":"Htseq\u2013a Python Framework to Work With High-Throughput Sequencing Data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"key":"B27","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/nbt.2931","article-title":"Normalization of RNA-seq Data Using Factor Analysis of Control Genes or Samples","volume":"32","author":"Risso","year":"2014","journal-title":"Nat Biotechnol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"D267","DOI":"10.1093\/nar\/gkh061","article-title":"The Unified Medical Language System (Umls): Integrating Biomedical Terminology","volume":"32","author":"Bodenreider","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0308531101","article-title":"Metagenes and Molecular Pattern Discovery Using Matrix Factorization","volume":"101","author":"Brunet","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B30","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/1471-2105-11-367","article-title":"A Flexible R Package for Nonnegative Matrix Factorization","volume":"11","author":"Gaujoux","year":"2010","journal-title":"BMC Bioinf"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1143","article-title":"Dgidb 3.0: A Redesign and Expansion of the Drug\u2013Gene Interaction Database","volume":"46","author":"Cotto","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp631","article-title":"Hpdi: A Database of Experimental Human protein-DNA Interactions","volume":"26","author":"Xie","year":"2010","journal-title":"Bioinformatics"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/ard.42.2.142","article-title":"Histocompatibility Antigens in Psoriasis, Psoriatic Arthropathy, and Ankylosing Spondylitis","volume":"42","author":"Armstrong","year":"1983","journal-title":"Ann Rheum Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)12004-9","article-title":"Classification of Inflammatory Arthritis by Enthesitis","volume":"352","author":"McGonagle","year":"1998","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03132","article-title":"RUNX3 and T-bet in Immunopathogenesis of Ankylosing Spondylitis - Novel Targets for Therapy","volume":"10","author":"Vecellio","year":"2019","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.biopha.2018.01.108","article-title":"Immune Cells Involved in the Pathogenesis of Ankylosing Spondylitis","volume":"100","author":"Rezaiemanesh","year":"2018","journal-title":"BioMed Pharmacother"},{"key":"B38","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2004.031740","article-title":"Immunopathology of Psoriasis and Psoriatic Arthritis","volume-title":"Annals of the Rheumatic Diseases","author":"Veale","year":"2005"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.123","article-title":"Tnf-\u03b1 Gene Polymorphisms: Association With Disease Susceptibility and Response to Anti-TNF-\u03b1 Treatment in Psoriatic Arthritis","volume":"134","author":"Murdaca","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1517\/14740338.2012.630388","article-title":"Update Upon Efficacy and Safety of TNF-\u03b1 Inhibitors","volume":"11","author":"Murdaca","year":"2012","journal-title":"Expert Opin Drug Saf"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209124.30","article-title":"A1.30 A Key Role of S100A9 in the Pathogenesis of Psoriatic Arthritis in TTP\/S100 Deficient Mice","volume":"75","author":"Fr\u00f6hling","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.03.008","article-title":"T-Cells Interact With B Cells, Dendritic Cells, and Fibroblast-Like Synoviocytes as Hub-Like Key Cells in Rheumatoid Arthritis","volume":"70","author":"Hu","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"B43","article-title":"The Central Role of T Cells in Rheumatoid Arthritis","volume":"25","author":"Cope","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.12.013","article-title":"Neutrophils in Rheumatoid Arthritis: More Than Simple Final Effectors","volume":"9","author":"Casc\u00e3o","year":"2010","journal-title":"Autoimmun Rev"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2016.91","article-title":"Macrophage Heterogeneity in the Context of Rheumatoid Arthritis","volume":"12","author":"Udalova","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191421","article-title":"NK Cell\u2013Derived GM-CSF Potentiates Inflammatory Arthritis and is Negatively Regulated by CIS","volume":"217","author":"Louis","year":"2020","journal-title":"J Exp Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/art.27224","article-title":"Systemic Sclerosis and Lupus: Points in an Interferon-Mediated Continuum","volume":"62","author":"Assassi","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B48","doi-asserted-by":"publisher","first-page":"154731","DOI":"10.1016\/j.cyto.2019.05.018","article-title":"Coordination Between Innate Immune Cells, Type I Ifns and IRF5 Drives SLE Pathogenesis","volume":"132","author":"Matta","year":"2020","journal-title":"Cytokine"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0212095","article-title":"Genetic Susceptibility to Lupus: The Biological Basis of Genetic Risk Found in B Cell Signaling Pathways","volume":"92","author":"Vaughn","year":"2012","journal-title":"J Leukoc Biol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02452","article-title":"Unraveling SSc Pathophysiology; The Myofibroblast","volume":"9","author":"Van Caam","year":"2018","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902199","article-title":"A Distinct Subset of Proinflammatory Neutrophils Isolated From Patients With Systemic Lupus Erythematosus Induces Vascular Damage and Synthesizes Type I Ifns","volume":"184","author":"Denny","year":"2010","journal-title":"J Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1126\/SCITRANSLMED.3001201","article-title":"Netting Neutrophils are Major Inducers of Type I Ifn Production in Pediatric Systemic Lupus Erythematosus","volume":"3","author":"Garcia-Romo","year":"2011","journal-title":"Sci Transl Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00428","article-title":"Nets: The Missing Link Between Cell Death and Systemic Autoimmune Diseases","volume":"3","author":"Darrah","year":"2012","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203041","article-title":"TLR9 Independent Interferon \u03b1 Production by Neutrophils on NETosis in Response to Circulating Chromatin, a Key Lupus Autoantigen","volume":"73","author":"Lindau","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B55","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/ncpgasthep0528","article-title":"Mechanisms of Disease: Pathogenesis of Crohn\u2019s Disease and Ulcerative Colitis","volume":"3","author":"Sartor","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"105040","DOI":"10.1016\/j.phrs.2020.105040","article-title":"Targeting T Cells in Inflammatory Bowel Disease","volume":"159","author":"Giuffrida","year":"2020","journal-title":"Pharmacol Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01296","article-title":"Innate Lymphoid Cells in Intestinal Inflammation","volume":"8","author":"Geremia","year":"2017","journal-title":"Front Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00961","article-title":"Human Gut-Associated Natural Killer Cells in Health and Disease","volume":"10","author":"Poggi","year":"2019","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"59","DOI":"10.12793\/tcp.2019.27.2.59","article-title":"A Review of Computational Drug Repurposing","volume":"27","author":"Park","year":"2019","journal-title":"Transl Clin Pharmacol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.01.012","article-title":"A Pilot Randomized Trial of a Human Anti-Interleukin-6 Receptor Monoclonal Antibody in Active Crohn\u2019s Disease","volume":"126","author":"Ito","year":"2004","journal-title":"Gastroenterology"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X17735756","article-title":"Anti-Interleukin and Interleukin Therapies for Psoriasis: Current Evidence and Clinical Usefulness","volume":"9","author":"Tsai","year":"2017","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"B62","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2474-12-153","article-title":"Efficacy and Safety of the Human anti-IL-1beta Monoclonal Antibody Canakinumab in Rheumatoid Arthritis: Results of a 12-Week, Phase II, Dose-Finding Study","volume":"12","author":"Alten","year":"2011","journal-title":"BMC Musculoskelet Disord"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.023176","article-title":"Open Label Trial of Anakinra in Active Ankylosing Spondylitis Over 24 Weeks","volume":"64","author":"Haibel","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"B64","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12969-017-0147-3","article-title":"Inflammatory Bowel Disease Following anti-interleukin-1-treatment in Systemic Juvenile Idiopathic Arthritis","volume":"15","author":"H\u00fcgle","year":"2017","journal-title":"Pediatr Rheumatol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209275","article-title":"Evidence of Response to IL-6 Inhibition in Some Cases of Refractory Spondyloarthritis Associated Peripheral Synovitis","volume":"75","author":"Merashli","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314562","article-title":"Randomised Trial and Open-Label Extension Study of an Anti-Interleukin-6 Antibody in Crohn\u2019s Disease (ANDANTE I and II)","volume":"68","author":"Danese","year":"2019","journal-title":"Gut"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.068064","article-title":"Study of Active Controlled Monotherapy Used for Rheumatoid Arthritis, an IL-6 Inhibitor (SAMURAI): Evidence of Clinical and Radiographic Benefit From an X Ray Reader-Blinded Randomised Controlled Trial of Tocilizumab","volume":"66","author":"Nishimoto","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.11.022","article-title":"Il-6 Differs From TNF-\u03b1: Unpredicted Clinical Effects Caused by IL-6 Blockade in Psoriasis","volume":"137","author":"Blauvelt","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i45.12963","article-title":"First Case Report of Exacerbated Ulcerative Colitis After anti-interleukin-6R Salvage Therapy","volume":"21","author":"Atreya","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210322","article-title":"Tofacitinib in Patients With Ankylosing Spondylitis: A Phase II, 16-Week, Randomised, Placebo-Controlled, Dose-Ranging Study","volume":"76","author":"Van Der Heijde","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz186","article-title":"JAK Efficacy in Crohn\u2019s Disease","volume":"14","author":"Rogler","year":"2019","journal-title":"J Crohn\u2019s Colitis"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s40265-017-0835-9","article-title":"Tofacitinib: A Review in Rheumatoid Arthritis","volume":"77","author":"Dhillon","year":"2017","journal-title":"Drugs"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1177\/0300060519847414","article-title":"Efficacy and Safety of Tofacitinib for the Treatment of Chronic Plaque Psoriasis: A Systematic Review and Meta-Analysis","volume":"47","author":"Tian","year":"2019","journal-title":"J Int Med Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.249","article-title":"Plerixafor With and Without Chemotherapy in Poor Mobilizers: Results From the German Compassionate Use Program","volume":"46","author":"H\u00fcbel","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2015.10","article-title":"Integrin-Based Therapeutics: Biological Basis, Clinical Use and New Drugs","volume":"15","author":"Ley","year":"2016","journal-title":"Nat Rev Drug Discovery"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3528","article-title":"Analysis of Five Chronic Inflammatory Diseases Identifies 27 New Associations and Highlights Disease-Specific Patterns At Shared Loci","volume":"48","author":"Ellinghaus","year":"2016","journal-title":"Nat Genet"},{"key":"B77","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1006\/clim.2002.5223","article-title":"Alteration in Expression of Beta 2 Integrins on Lamina Propria Lymphocytes in Ulcerative Colitis and Crohn\u2019s Disease","volume":"104","author":"Bernstein","year":"2002","journal-title":"Clin Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.11.018","article-title":"NK Cells in Autoimmune Diseases: Linking Innate and Adaptive Immune Responses","volume":"17","author":"Gianchecchi","year":"2018","journal-title":"Autoimmun Rev"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2016.01.001","article-title":"Lifitegrast, a Novel Integrin Antagonist for Treatment of Dry Eye Disease","volume":"14","author":"Perez","year":"2016","journal-title":"Ocul Surf"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.669400\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T06:23:15Z","timestamp":1621837395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.669400\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,24]]},"references-count":79,"alternative-id":["10.3389\/fimmu.2021.669400"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.669400","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,24]]},"article-number":"669400"}}